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Original Article
ABSTRACT
BACKGROUND
Although stenting for the treatment of large and multiple common bile duct stones has been 
acceptable to everyone, its efficacy and outcome have not been studied in comparison with other 
endoscopic procedures. The purpose of this study was to compare the consequences of stenting 
and endoscopic papilla balloon dilatation for the treatment of large and multiple common bile 
duct stones.
METHODS
In a double-blind clinical trial, of 431 patients with bile duct stones referred to the treatment 
center, 64 patients with multiple common bile duct stones ( ≥ 3) and more than 15 cm were selected 
for the study, then by random allocation rule the participants were allocated in two groups. They 
were entered into two different endoscopic papillary balloon dilatation (EPBD) and common bile 
ducts stenting treatments so that both procedures were performed by a person. Both groups were 
assessed from the point of views therapeutic outcomes such as duct cleaning, pancreatitis, isolated 
pain, and duct rupture. Data were collected by a self-made questionnaire that was used before and 
after the procedure to obtain the needed information. Then data were analyzed using SPSS software 
version 22 and descriptive and analytical tests were used as appropriated.
RESULTS
Although the duct cleaning and the complete removal of the stones in the stenting treatment 
procedure was 93.8%, and in EPBD was 78.3%, no significant difference was observed between 
the two groups (p = 0.14). Pancreatitis significantly increased after the first and second endoscopic 
retrograde cholangiopancreatography (ERCP) in the stent group compared with EPBD (p = 0.02). 
Also, the most frequent cases of isolated pain were in the endoscopic group EPBD (p = 0.0). However, 
the occurrence of perforation after first ERCP and EPBD was zero, but in the second stage of 
ERCP, 3.3% of the patients had perforations (p = 0.99). The results indicated that the shape of the 
stone (circular and angled) was not effective in the result of treatment in the two groups.
CONCLUSION
The results of this study indicated that in case of experience and skill in conducting the ERCP, 
common bile duct stenting is still the first line of treatment for large and multiple stones of the 
common bile ducts.
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INTRODUCTION
7-12% of patients undergoing cholecystectomy for the 
treatment of symptomatic gallstones have common bile 
duct (CBD) stones. These patients are good candidates for 
endoscopic retrograde cholangiopancreatography (ERCP).1 
ERCP with endoscopic sphincterotomy and removing stones 
by balloons and baskets are commonly used to treat CBD 
stones, so that, between 85-95% of all bile duct stones can 
be effectively treated by these commonly used methods.2,3
Difficult access to the biliary duct stones due to the 
primary diverticulum, sigmoid shape bile duct stone, after 
billroth,2 gastrojejunostomy, a large number of stones, 
large stone size (above 15 mm), non-natural stone location, 
and abnormally shaped stone cause the treatment process 
by common endoscopic methods a difficult and chal-
lenging one.4-6
Although CBD stones with a maximum diameter of 
15 cm can be evicted by endoscopic sphincterotomy, 
with the increase in stone diameter the chance of evicting 
a stone dropped so that the stones with a diameter larger 
than 2 cm should be broken before leaving the duct.7-9
Currently, for the treatment of stones known as complex 
stones, several methods such as lithotripsy, electro-hydraulic 
lithotripsy, laser lithotripsy, endoscopic papillary balloon 
dilatation, sphincterotomy, and stenting are used.8 
Electrohydraulic lithotripsy (EHL) is associated with 
increased risk of duct rapture 4 and endoscopic papillary 
balloon dilatation is associated with an increased risk of 
pancreatitis.10 Also lithotripsy is not available in all centers 
and is very expensive.
For elderly patients for whom surgical procedures and 
endoscopic procedures are harmful, stenting is a very 
suitable method.11,12 The study by Yay and colleagues 
suggests that stenting is an appropriate and practical 
way to treat complicated biliary stones in older people.13 
Also, the results of other studies indicate that stent has 
been able to help evicting stones from bile ducts by reducing 
the number and size of stones over a period of 2 months .13
Although not timely treatment of common biliary duct 
stones, as well as their removal, is associated with seri-
ous complications such as pancreatitis and cholangitis. 
The use of procedures with less negative consequences 
is very important for these patients. The purpose of this 
study was to compare the success rate and side effects 
of treatment of large (above 15 mm) and multiple (more 
than 3 stones) CBD stones by stenting process and other 
endoscopic procedure in the patients with Large and 
Multiple Common Bile Duct Stones referring to Shahid 
Beheshti Medical Center affiliated to Qom University of 
Medical Sciences.
MATERIALS AND METHODS
The current randomized controlled trial study was 
conducted on patients with large and multiple common 
bile duct stones who referred to Shahidbeheshti Teaching 
Hospital in Qom, Iran. This project was approved by 
Qom university of medical sciences ethics Committee (IR.
MUQ.REC.1394.133.) The research project was registered 
in the Iranian Registry of Clinical Trials (code no. 
IRCT2017020831252N). In a connivance sampling from 
413 patients referred to Shahidbeheshti Teaching Hospital 
in Qom 64 patients had inclusion criterion (CBD stones 
larger than 15 cm and the number of stones (3 ≤). The 
patients with coagulation disorder and ERCP were excluded 
from the study. The selected cases were allocated in two 
groups based on the random allocation rule to receive 
stenting intervention or endoscopic papillary balloon 
dilation (EPBD) for removing stones from the duct.
Dilatation balloon was done based on the diameter of 
CBD and the size of the ampule Water so that dilatation 
was between 15 to 18 mm and time between 45 and 60 
seconds with the endophex balloon of Germany. Plastic 
stents with the radius of 10 French and length of 8-12 cm 
from Endo-flex Company (Germany) were used. Initially, 
demographic information and data from the imaging 
study (sonography, and Magnetic Resonance Cholangio-
pancreatography) including the size, number, and shape 
of the stone were measured so that the size of the stone 
was indicated with fluoroscopy by injection of radiocontrast 
agent in the CBD and seeing the stones with radiographic 
images during ERCP. Then patient follow-up was assessed 
from the point of view of the therapeutic outcomes after 
ERCP, such as duct cleaning, pancreatitis, isolated pain, and 
duct rupture. It should be noted that in the stenting group, the 
patients were evaluated in the first stage after the stent and 
in the second stage for the removal of stones with regard to 
the therapeutic outcomes. Data were analyzed using SPSS 
software version 22 and descriptive and analytical tests such 
as paired t test, independent t test, Chi-square test, and one-
way ANOVA were used as appropriated.
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RESULTS
The frequency of women in the stent group was 60% 
and in the EPBD group was 40%. The frequency of men 
in the stent group was 40% and in the EPBD group was 
60%, so that the Chi-square test detected there was no 
significant difference between the two groups in terms of 
sex. The mean age of the two groups of stents and EPBD 
was 32.81 and 32.19 respectively. Mann-Whitney test 
showed that there was no significant difference between 
the two groups (p = 0.893).
There were no statistically significant differences 
between the two intervention groups in terms of diameter 
and number of stones in the common ducts. The mean 
diameter of the stones in stent and EPBD group was 17.4 ± 
2.86 and 37.17 ± 2.19 mm, respectively (p = 0.96).
The mean and standard deviation of the number of stones 
in the stenting group was 3.31 ± 1.32 and in the endoscopic 
treatment of EPBD was 2.99 ± 1.247. p = 0.075 indicated that 
there was no significant difference between the two groups.
The rate of success of stone removal from the duct in 
terms of stone shape in the two groups of stents and EPBD 
did not have statistically significant difference (table 1).
The results indicated that the therapeutic outcomes, 
in the two groups of stenting and EPBD treatment, were 
not significantly different in many dimensions (table 2).
Based on the Mantel-Haenszel test, no meaning-
ful statistical relationship was found between the stone 
shape and the success rate (p = 0.12).The results detected 
that in the stent group, there was no specific complication 
but the complication was related to the ERCP.
DISCUSSION
The purpose of this study was to compare the success 
rate and side effects of large (above 15 mm) and multiple 
(more than 3 stones) CBD stones treatment by stenting 
process and other endoscopic procedure in the patients 
referring to Shahid Beheshti Medical Center affiliated to 
Qom University of Medical Sciences.
The results indicate that the frequency of successful 
removal of large and multiple stones was 94% and 78% 
& respectively by stenting and 78% endoscopic papillary 
balloon dilatation. Although there was no statistically 
significant difference between the two groups, the 
success rate of the removal of large and multiple stones 
Table 2: The therapeutic outcomes of stenting and endoscopic papillary balloon dilatation groups in patients with large and multiple 
common biliary duct stones
Therapeutic intervention
                         The consequence of intervention
EPBD First step CBD stenting Second step CBD stenting P value 
Count % Count % Count %
Complete removal of stone 25 78.1 - - 30 93.8 0.14
Pancreatitis 2 6.2 6 18.8 0 0 0.025
Cholangitis 0 0 0 0 0 0 0
Isolated pain 6 18.8 1 3.1 1 3.1 0.046
Perforation 0 0 0 0 1 3.1 0.99
Table 1: Establishment of bile ducts flow in patients with large and multiple common bile duct stones in stenting and endoscopic papillary 
balloon dilatation groups based on stone shape
Therapeutic 
intervention Stone shape
Success in establishing flow in the duct
Complete success Relative success Failure
Count % Count % Count %
Stent 
Angled 4 57.1 0 0 3 42.9
Circular 21 84 0 0 4 16
Total 25 78.1 0 0 7 21.9
EPBD
Angled 9 90 0 0 1 10
Circular 21 95.5 1 4.5 0 0
Total 30 93.8 1 3.1 1 3.1
207Hormati et al.
Middle East J Dig Dis/ Vol.11/ No.4/October 2019
and ultimately the complete opening of the duct has been 
more successful by stenting than endoscopic papillary 
balloon dilatation.
In the study by Horiuchi the success rate of removal of 
stones was 93%, 14 the HUNG study indicates the success 
rate of removal of stone as 94%. In the study by Hui, the 
success rate of removal of stone was 94.7%, 14 and in the 
study by YE, the success rate of removal of stone was 94.1%. 
These results confirm the results of the current study.15
Although this rate was significantly reduced in the 
study of ASLAN and colleagues, only 62.5% of the patients 
had experienced a successful removal of stone by baskets, 
which was due to the fact that patients were not first 
treated with baskets, but the previous treatment procedures 
had not been successful. 16
In a comparative study conducted by Hoye and co-
workers, the degree of duct clearing in electrohydraulic 
lithotripsy was 76.5% and 94.7% in the stent method. 
The result of this study is consistent with the current 
study and reflects the fact that stenting is the first line 
of treatment in the successful clearing of CBD stones.17 
Jane Sca and colleagues concluded that 6 months after 
stenting, removal of big stone from bile ducts, was very 
significant in most patients.18
Di Giorgio P and co-workers in their study concluded 
that stenting was a simple and safe method for managing 
large and multiple stones, while many of these patients were 
not suitable for surgical procedures or are at high risk.19
Chiro Yasuda1 and Takao Iota, in their study, conclude 
that although there are various methods for treating biliary 
stones, endoscopic sphincterotomy can be done with 
balloon or first-line catheter reabsorption of bile ducts.5 
Chan AC, in the conclusion of his study, says that 
although it is difficult to get out of the duct with the 
enlargement of the stone, it will be very easy to remove 
large and multiple stones after stenting.20 Also Katsin 
Loos and co-workers indicate that endoscopy with stenting 
is one of the best methods for clearing bile ducts in large 
and difficult stones.21
The result of this study indicated that pancreatitis in 
the treatment with stents in the first and second stages 
was significant compared with EPBD treatment. So that 
in the first stage, 18% of patients, and in the second stage 
of the stenting, none of the patients had pancreatitis, but 
about 6% of the patients had pancreatitis during treatment 
with EPBD. However, the stent was very successful in 
removing the entire stone and opening the bile duct, but 
complications of pancreatitis after the procedure are a 
threat to patients.
In the Horiuchi study, the incidence of pancreatitis 
after the first stage of the stent was 5%, and in the Hong 
study, it was 1.9%. Also in the study by Jagielski and 
colleagues, it was 5.44%.14,22,23 In a study by Edwina 
Chan and others, out of 1,000 patients who underwent 
ERCP and 87 patients after the ERCP, they had unplanned 
complications in hospital, and 41.1% of the patients had 
pancreatitis so that the incidence of pancreatitis in the 
entire under study population was 3.6%.24 The high 
incidence of pancreatitis in this study can be due to the 
lack of sufficient experience of operators. Therefore, one 
of the most important factors in the treatment with stent 
was the sufficient experience of people working with 
endoscopic devices, especially the ERCP device.25,26
The result of the study shows that the incidence of 
cholangitis in the two groups was equal to zero percent. 
In the study of Edwina Chan and colleagues, the incidence 
of cholangitis was reported to be 3%, while the population 
surveyed was 1,000.23 In the Horiuchi study, the incidence 
of cholangitis in the first stage of stenting was 13%, and 
in the Hong study, this rate was reported as 3.8% after 
the first stage of stenting.21 Differences in the results of 
the studies indicated that the present study examined 
the presence of cholangitis in patients during the hospital 
admission and also 2 weeks after the procedure, while in 
the Horiuchi study, this rate was 6 months after the 
procedure. So, the results indicate that following up 
patients after ERCP in terms of infectious and inflammatory 
outcomes should not be limited to the short period of 
time during hospital admission in the ward and just after 
the procedure, but in a long-term period, patients should 
be checked in line with complications and possible outcome.
 The result of the study showed that the rate of occurrence of 
isolated pain (single pain without increasing pancreatic en-
zymes and the absence of evidence based on pancreatitis and 
cholangitis) in the EPBD group was 18.8, but after the first and 
second ERCP, it was 3.1% and 3.1, respectively. There was a 
significant difference between the two groups in the oc-
currence of pain after the treatment procedure. This difference 
can be attributed to the higher pressure exerted on the sphincter 
during the balloon dilatation for the extraction of large stones.27
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In the study of Edwin and colleagues, although many 
of the risk factors associated with hospital admission and 
the side effects of ERCP have been reported but in your 
conclusion suggested that many patients had severe pain 
after ERCP not only this pain was not expressed by the 
patients but also there was not suitable evidence to 
detected this pain related to one of the complications of 
the procedure,24 we had this pattern of pain in our patients.
Although perforation has not been occurred in the 
EPBD group and the first stage of stenting, it was 3.1% 
in the second stage of stenting.
In the study of Asad and colleagues, in line with endo-
scopic management of CBD in a 5-year process from 2011 
to 2016, 129 patients with CBD stones, the results showed 
that in none of the cases treated by ERCP, duct rupture was 
reported.27 While Andrewlee and others in their study 
concluded that ERCP had severe and moderate compli-
cations, and in their review under the title of investigating 
post-ERCP complications, the rate of perforation in 16885 
patients under ERCP from 1977 to 2006, was reported to be 
6%.28 Also in the study of Salminin and Lini for assessing 
post-ERCP complications in 2555 patients, perforation rate 
was only 0.2% and in the conclusion part of their study, 
it was indicated that lethal complications after ERCP were 
rare in their study.29 Kharbutli B, VelanovichV suggest that 
the exploration of CBD stones by the endoscope has less 
mortality and morbidity rate.30 Thus, in other studies, the 
low level of perforation and threatening complications was 
reported very poorly.31
CONCLUSION
Although large and multiple biliary stones could be 
treated with several endoscopic methods but the stenting 
method is a selective therapeutic approach with full duct 
clearance and minimal side effect if the procedure is 
performed by a person with full experience and skill.
Study limitations:
The low sample size of this study is due to the low 
frequency of patients with large and multiple CBD stones. 
Therefore, researchers believe that more valuable studies 
with larger sample size is needed to achieve a better result.
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